Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Observations

Morning Enzymatic Activity of DPP-4 Is Differentially Altered by Sleep Loss in Women and Men

  1. Frida H. Rångtell1⇑,
  2. Felix Schmidt1,
  3. Josefine Würfel2,3,
  4. Swathy Karamchedu1,4,
  5. Peter Andersson1,
  6. Heike Vogel2,3 and
  7. Christian Benedict1
  1. 1Department of Neuroscience, Uppsala University, Uppsala, Sweden
  2. 2Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany
  3. 3German Center for Diabetes Research, München-Neuherberg, Germany
  4. 4Centre for Cognitive Neuroscience, Neuroscience and Behavioral Disorders Program, Duke-NUS Medical School, Singapore
  1. Corresponding author: Frida H. Rångtell, frida.rangtell{at}neuro.uu.se.
Diabetes Care 2018 Feb; 41(2): e10-e11. https://doi.org/10.2337/dc17-1762
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

No study to date has investigated whether the activity of circulating dipeptidyl peptidase 4 (DPP-4) is affected by sleep loss. DPP-4 is an enzyme that catalyzes a variety of important physiological processes in humans by cleavage of, e.g., the incretin hormones glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (1). Both chronic sleep loss and an increased activity of DPP-4 have been implicated in the development of several diseases, including type 2 diabetes (1–4).

Twenty-five normal-weight healthy adults (aged 18–28 years; 13 women, using oral monophasic contraceptives) participated in two in-laboratory experimental conditions separated by about 1 week: one night of regular sleep (scheduled 2230–0630) and one night of total sleep loss, in a counterbalanced order. In the morning (∼0730), fasting blood samples were taken to measure the enzymatic activity of DPP-4, as previously described (3). The effects of sleep loss on DPP-4 activity were examined by using a linear mixed model (restricted maximum likelihood method; scaled identity as covariance matrix) with the fixed factors experimental condition (sleep/total sleep deprivation) and sex (women/men), as well as their interaction. All participants gave written informed consent, and the study was approved by the regional ethics review board in Uppsala (dnr 2015/347).

During the experimental sleep condition, participants slept 7.36 ± 0.05 h (mean ± SEM), as measured by polysomnography. The enzymatic activity of circulating DPP-4 was similar irrespective of whether the participants had been asleep or awake during the preceding night (Fig. 1, left panel; F1,44 = 0.007; P = 0.932). Men generally had higher DPP-4 activity than the women (Fig. 1, middle panel; F1,44 = 19.2; P = 0.00007). Importantly, sleep loss altered DPP-4 activity differently in male and female participants (Fig. 1, right panel; F1,44 = 5.1; P = 0.029 for experimental condition × sex).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Measured enzymatic activity of circulating DPP-4 after a full night of sleep and after a night of total sleep loss in women and men. Left: DPP-4 activity following sleep (black bars) and total sleep deprivation (TSD) (red bars). Numbers are derived from the estimated means for the main effect of experimental condition (sleep/TSD) in the linear mixed model (N = 25). Middle: DPP-4 activity in women (N = 13) and men (N = 12). Numbers are derived from the estimated means for the main effect of sex in the linear mixed model. Right: Mean DPP-4 activity following sleep as well as TSD, split by sex. Wilcoxon signed rank test was used to test for differences in DPP-4 activity between the experimental conditions (sleep/TSD) in women (N = 11) and men (N = 12), respectively. The linear mixed model showed an interaction between experimental condition and sex (P = 0.029). The direction of the interaction is demonstrated by this graph. One of the data points for two of the participating women are missing due to technical and blood drawing failure. Therefore, these two participants were not part of the Wilcoxon signed rank tests (but included in the linear mixed model), nor were they included in the means used to generate the right panel. Error bars represent SEM. AU, arbitrary units; n.s., not significant. *P < 0.05; ***P < 0.001.

Activity of circulating DPP-4 increased by about 14% in women, whereas it decreased by about 11% in men following sleep loss. Although the changes in women are smaller than previously observed increases in DPP-4 activity in patients with type 2 diabetes compared with control subjects (∼29%) (4), the change in DPP-4 activity seen in women following sleep loss may nonetheless be of clinical concern. Although our findings could be seen as a favorable metabolic response of men to sleep loss, it must be noted that chronic poor sleep patterns increase the risk of developing metabolic diseases in both sexes (2). Moreover, we only collected one morning fasting blood sample following total sleep loss. Thus, one has to be cautious when extrapolating our findings to different types of sleep loss, other times of the day, and nonfasting conditions. The wider metabolic implications of our findings, e.g., GLP-1, remain to be elucidated. A previous study found decreased GLP-1 concentrations during afternoon hours in women but not men following short sleep (5). In contrast, blood concentrations of the hunger-promoting hormone ghrelin were increased in men but not women following short sleep (5). In line with these results, our findings add to the emerging evidence suggesting that sleep loss may cause metabolic disruptions via separate pathways in men and women.

Article Information

Acknowledgments. The authors thank Misty Attwood and Nipuni Welihinda, Department of Neuroscience, Uppsala University, Uppsala, Sweden, and Pablo Vallejos, Fusion Plasma Physics, Royal Institute of Technology, Stockholm, Sweden, for their insightful comments on the manuscript.

Funding. This work was supported by the Swedish Folksam Research Foundation (to C.B.), the Novo Nordisk Foundation (NNF14OC0009349 to C.B.), the Swedish Brain Research Foundation (FO2016-0092 to C.B.), the Swedish Research Council (2015-03100 to C.B.), and the German Federal Ministry of Education and Research and the Brandenburg State (DZD grant 82DZD00302 to H.V.).

The funders did not have any role in study design or interpretation of the results, nor in the writing process.

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

Author Contributions. F.H.R. and C.B. designed the study. F.H.R., F.S., and C.B. analyzed the data. F.H.R., F.S., H.V., and C.B. interpreted the data. F.H.R., S.K., and P.A. collected the data. J.W. and H.V. analyzed the blood samples. All authors contributed to writing and have approved the final manuscript. F.H.R. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

  • Received August 23, 2017.
  • Accepted October 18, 2017.
  • © 2017 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Hildebrandt M,
    2. Reutter W,
    3. Arck P,
    4. Rose M,
    5. Klapp BF
    . A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence. Clin Sci (Lond) 2000;99:93–104
    OpenUrlCrossRefPubMed
  2. ↵
    1. Cappuccio FP,
    2. D’Elia L,
    3. Strazzullo P,
    4. Miller MA
    . Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010;33:414–420
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Baumeier C,
    2. Schlüter L,
    3. Saussenthaler S, et al
    . Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Mol Metab 2017;6:1254–1263
    OpenUrl
  4. ↵
    1. Lee SA,
    2. Kim YR,
    3. Yang EJ, et al
    . CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2013;98:2553–2561
    OpenUrlCrossRefPubMed
  5. ↵
    1. St-Onge MP,
    2. O’Keeffe M,
    3. Roberts AL,
    4. RoyChoudhury A,
    5. Laferrère B
    . Short sleep duration, glucose dysregulation and hormonal regulation of appetite in men and women. Sleep 2012;35:1503–1510
    OpenUrlPubMed
PreviousNext
Back to top
Diabetes Care: 41 (2)

In this Issue

February 2018, 41(2)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Morning Enzymatic Activity of DPP-4 Is Differentially Altered by Sleep Loss in Women and Men
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Morning Enzymatic Activity of DPP-4 Is Differentially Altered by Sleep Loss in Women and Men
Frida H. Rångtell, Felix Schmidt, Josefine Würfel, Swathy Karamchedu, Peter Andersson, Heike Vogel, Christian Benedict
Diabetes Care Feb 2018, 41 (2) e10-e11; DOI: 10.2337/dc17-1762

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Morning Enzymatic Activity of DPP-4 Is Differentially Altered by Sleep Loss in Women and Men
Frida H. Rångtell, Felix Schmidt, Josefine Würfel, Swathy Karamchedu, Peter Andersson, Heike Vogel, Christian Benedict
Diabetes Care Feb 2018, 41 (2) e10-e11; DOI: 10.2337/dc17-1762
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Creating Composite Indices From Continuous Variables for Research: The Geometric Mean
  • DPP-4 Inhibitors and Respiratory Infection: A Systematic Review and Meta-analysis of the Cardiovascular Outcomes Trials
  • Early Worsening of Diabetic Nephropathy in Type 2 Diabetes After Rapid Improvement in Chronic Severe Hyperglycemia
Show more e-Letters: Observations

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.